News

Yakima Herald4hOpinion
Other Views: How to cut U.S. drug prices without hurting innovation
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U ...
Editorial: How to cut US drug prices without hurting innovation
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U ...
Opinion
Longview News-Journal1hOpinion
Other voices: How to cut U.S. drug prices without hurting innovation
The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other rich countries. It ...
Opinion
The Eagle-Tribune3hOpinion
Their View: How to cut drug prices without hurting innovation
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 ...
Are weight loss drugs safe? Learn some of the side effects
Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...
Asian shares slide and US futures and dollar drop after Wall Street's winning week
HONG KONG (AP) — Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the ...
Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk and GSK in focus
In another note of news, a key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs -- Novo Nordisk's ( NVO) Wegovy (semaglutide) and Eli Lilly's ( LLY) Zepbound ...